4//SEC Filing
Russell Angus C. 4
Accession 0001209191-22-046966
CIK 0000025743other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 6:00 AM ET
Size
7.5 KB
Accession
0001209191-22-046966
Insider Transaction Report
Form 4
Russell Angus C.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-08-18+1,984→ 5,792 total - Exercise/Conversion
Restricted Stock Units
2022-08-18−1,984→ 0 totalExercise: $0.00→ Common Stock (1,984 underlying)
Footnotes (3)
- [F1]On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022.
- [F2]Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
- [F3]The RSUs vested on July 1, 2022.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001534002
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 6:00 AM ET
- Size
- 7.5 KB